October 9–11, 2025
Sorocaba, Brazil
.png)
November 21–23, 2025
Hong Kong SAR, China
We are excited to announce that we are accepting applications for the ISPE Peer Mentoring Program, a pilot program developed by the ISPE Membership Committee. We invite all eligible ISPE members to join small, carefully coordinated groups of 5-6 peers, matched on career sector, years of experience, and meeting time preferences, when possible. Peer-to-peer mentoring will provide invaluable career development opportunities with peer advice, allowing members to enhance professional skills, broaden perspectives, and build a supportive community within ISPE. Visit our page for more details.
ISPE is pleased to announce the induction of new ISPE Fellows this year. The induction ceremony is scheduled for ISPE's Annual Meeting 2024 in Berlin, Germany
Click here for details: New ISPE Fellows 2024
The ISPE Board of Directors is pleased to announce the results of the recent election of 6 new directors to the Board, who will take office at our annual meeting in August in Berlin, Germany.
Click here for details.
When: Friday, October 10, 2025, 10 a.m. to 11 a.m. Eastern Daylight Time
Topic: PDS Best Paper of 2024 - Lack of Evidence for Vaccine-Associated Enhanced Disease From COVID-19 Vaccines Among Adults in the Vaccine Safety Datalink
Description: : Pharmacoepidemiology and Drug Safety (PDS), the official journal of ISPE, presents the Ronald D. Mann Best Paper Award each year to the strongest contribution within a given volume of the journal. The award for 2024 is presented to Dr. Thomas G. Boyce and collaborators for their paper Lack of Evidence for Vaccine-Associated Enhanced Disease From COVID-19 Vaccines Among Adults in the Vaccine Safety Datalink. The paper aimed to detect signals for vaccine-associated enhanced disease (VAED), a theoretical safety concern for all new vaccines, especially those developed using the novel platforms, among adults vaccinated against COVID-19. The study results provide further evidence for lack of VAED with COVID-19 vaccines. In this webinar, co-authors Dr. Boyce and Dr. McClure will present study findings from both clinical and statistical perspectives, followed by comments by Pharmacoepidemiology and Drug Safety associate editor Dr. Filion.
Speaker's names:
Dr. David L. McClure
Dr. Thomas G. Boyce
Dr. Kristian Filion
Moderator: Dr. Hemalkumar B. Mehta
Register in advance for this webinar
Interested in presenting a webinar? Submit a webinar proposal here
